Office of the Director, National Institutes of Health; Notice of Meeting, 28235-28236 [2013-11352]
Download as PDF
Federal Register / Vol. 78, No. 93 / Tuesday, May 14, 2013 / Notices
Cancer Control, National Institutes of Health,
HHS)
Dated: May 7, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–11347 Filed 5–13–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
mstockstill on DSK4VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Novel
Imaging Agents to Expand the Clinical
Toolkit for Cancer Diagnosis, Staging, and
Treatment.
Date: May 29, 2013.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute, 9609
Medical Center Drive, Room 4W034,
Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Sonya Roberson, Ph.D.,
Health Scientist Administrator, Resources
and Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, 9609 Medical Center Drive, Room
7W116, Bethesda, MD 20892–8328, 240–276–
6347, robersos@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting date due to
scheduling conflicts.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Cancer
Theranostics II.
Date: June 3, 2013.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 9609
Medical Center Drive, Room 7W030,
Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Savvas C Makrides, Ph.D.,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
VerDate Mar<15>2010
16:52 May 13, 2013
Jkt 229001
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W246,
Bethesda, MD 20892–8328, 240–276–6374,
makridessc@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Companion
Diagnostics—Phase II.
Date: June 5, 2013.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 9609
Medical Center Drive, Room 7W032,
Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Adriana Stoica, Ph.D.,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W234,
Bethesda, MD 20892–8328, 240–276–6368,
Stoicaa2@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel,
Pharmacodynamic Assays TX2 of 2.
Date: June 6, 2013.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute, 9609
Medical Center Drive, Room 7W034,
Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Thomas M Vollberg, Ph.D.,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W102,
Bethesda, MD 20892–8328, 240–276–6341,
vollbert@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Biosensors
for Early Cancer Detection and Risk
Assessment.
Date: June 10, 2013.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 9609
Medical Center Drive, Room 6W032,
Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Kenneth L. Bielat, Ph.D.,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 9609
Medical Center Drive, Room 7W244,
Bethesda, MD 20892–8329, 240–276–6373,
bielatk@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel,
Radioprotector/Mitigator Development to
Decrease Normal Tissue Injury During
Radiotherapy.
Date: June 13, 2013.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W302, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Viatcheslav A
Soldatenkov, MD, Ph.D., Scientific Review
Officer, Special Review and Logistics Branch,
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
28235
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W254, Bethesda, MD 20892–
8329, 240–276–6378,
soldatenkovv@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel,
Development of a Molecular Diagnostic
Assay to Detect Basal-like Breast Cancer.
Date: June 13, 2013.
Time: 12:00 p.m. to 1:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 9609
Medical Center Drive, Room 6W032,
Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Sonya Roberson, Ph.D.,
Health Scientist Administrator, Resources
and Training Review Branch, Division Of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W116, Bethesda, MD 20892–8328,
240–276–6347, robersos@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Process
Analytic Technologies (PAT) for Biologics:
Innovative Methods for Monitoring and
Analyzing Product Quality.
Date: June 19, 2013.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 9609
Medical Center Drive, Room 2W034,
Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Thomas A. Winters, Ph.D.,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W268,
Bethesda, MD 20892–8328, 240–276–6386,
twinters@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: May 7, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–11345 Filed 5–13–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
E:\FR\FM\14MYN1.SGM
14MYN1
28236
Federal Register / Vol. 78, No. 93 / Tuesday, May 14, 2013 / Notices
Advisory Committee to the Director,
National Institutes of Health.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended because the premature
disclosure of program documents—PAC
and the discussions would likely to
significantly frustrate implementation of
recommendations.
license, or passport) and to state the
purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: https://
acd.od.nih.gov, where an agenda and
any additional information for the
meeting will be posted when available.
Dated: May 8, 2013.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–11352 Filed 5–13–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSK4VPTVN1PROD with NOTICES
Name of Committee: Advisory Committee
to the Director, National Institutes of Health.
Date: June 13–14, 2013.
Open: June 13, 2013, 9:00 a.m. to 12:00
p.m.
Agenda: NIH Director’s Report.
Place: National Institutes of Health,
Building 31, 6th Floor, Conference Room
6C6, 31 Center Drive, Bethesda, MD 20892.
Closed: June 13, 2013, 1:00 p.m. to 2:00
p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 6th Floor, Conference Room
6C6, 31 Center Drive, Bethesda, MD 20892.
Open: June 13, 2013, 2:00 p.m. to 5:00 p.m.
Agenda: Updates and discussions on other
committee business.
Place: National Institutes of Health,
Building 31, 6th Floor, Conference Room
6C6, 31 Center Drive, Bethesda, MD 20892.
Open: June 14, 2013, 9:00 a.m. to 1:00 p.m.
Agenda: ACD Biomedical Workforce
Working Group report.
Place: National Institutes of Health,
Building 31, 6th Floor, Conference Room
6C6, 31 Center Drive, Bethesda, MD 20892.
Contact Person: Gretchen Wood, Staff
Assistant, National Institutes of Health,
Office of the Director, One Center Drive,
Building 1, Room 103, Bethesda, MD 20892,
301–496–4272, woodgs@od.nih.gov.
National Cancer Institute Amended;
Notice of Meeting
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for
entrance onto the NIH campus. All
visitor vehicles, including taxicabs,
hotel, and airport shuttles will be
inspected before being allowed on
campus. Visitors will be asked to show
one form of identification (for example,
a government-issued photo ID, driver’s
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meetings
VerDate Mar<15>2010
16:52 May 13, 2013
Jkt 229001
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel, May
23, 2013, 11:30 a.m. to May 23, 2013,
03:30 p.m., National Cancer Institute—
Shady Grove, 9609 Medical Center
Drive, Room 7W032, Rockville, MD
20850 which was published in the
Federal Register on May 03, 2013,
78FR26056.
This notice is being amended due to
a change in the meeting date and time
from 11:30 a.m. to 3:30 p.m. on May 23,
2013 to 12:00 p.m. to 3:00 p.m. on May
22, 2013. The meeting is closed to the
public.
Dated: May 7, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–11349 Filed 5–13–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel, CS
Translational.
Date: June 4, 2013.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6120
Executive Blvd, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Sheo Singh, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
Executive Plaza South, Room 400C, 6120
Executive Blvd., Bethesda, MD 20892, 301–
496–8683, singhs@nidcd.nih.gov.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel,
Chemosensory Fellowship Application
Review.
Date: June 11, 2013.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6120
Executive Blvd., Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Shiguang Yang, DVM,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, NIDCD, NIH, 6120
Executive Blvd., Bethesda, MD 20892, 301–
496–8683.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel, HB
Fellowship Applications Review.
Date: June 12, 2013.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6120
Executive Blvd., Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Sheo Singh, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
Executive Plaza South, Room 400C, 6120
Executive Blvd., Bethesda, MD 20892, 301–
496–8683, singhs@nidcd.nih.gov.
Name of Committee: Communication
Disorders Review Committee.
Date: June 13–14, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Andrea B. Kelly, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, Scientific Review
Branch, NIDCD, NIH, 6120 Executive Blvd.,
Ste 400C, MSC 7180, Rockville, MD 20892,
(301) 496–8683, kellya2@nidcd.nih.gov.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel, NIDCD
Clinical Trial and Translational Research
Applications.
E:\FR\FM\14MYN1.SGM
14MYN1
Agencies
[Federal Register Volume 78, Number 93 (Tuesday, May 14, 2013)]
[Notices]
[Pages 28235-28236]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-11352]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
[[Page 28236]]
Advisory Committee to the Director, National Institutes of Health.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended because the premature disclosure of program
documents--PAC and the discussions would likely to significantly
frustrate implementation of recommendations.
Name of Committee: Advisory Committee to the Director, National
Institutes of Health.
Date: June 13-14, 2013.
Open: June 13, 2013, 9:00 a.m. to 12:00 p.m.
Agenda: NIH Director's Report.
Place: National Institutes of Health, Building 31, 6th Floor,
Conference Room 6C6, 31 Center Drive, Bethesda, MD 20892.
Closed: June 13, 2013, 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 6th Floor,
Conference Room 6C6, 31 Center Drive, Bethesda, MD 20892.
Open: June 13, 2013, 2:00 p.m. to 5:00 p.m.
Agenda: Updates and discussions on other committee business.
Place: National Institutes of Health, Building 31, 6th Floor,
Conference Room 6C6, 31 Center Drive, Bethesda, MD 20892.
Open: June 14, 2013, 9:00 a.m. to 1:00 p.m.
Agenda: ACD Biomedical Workforce Working Group report.
Place: National Institutes of Health, Building 31, 6th Floor,
Conference Room 6C6, 31 Center Drive, Bethesda, MD 20892.
Contact Person: Gretchen Wood, Staff Assistant, National
Institutes of Health, Office of the Director, One Center Drive,
Building 1, Room 103, Bethesda, MD 20892, 301-496-4272,
woodgs@od.nih.gov.
Any interested person may file written comments with the committee
by forwarding the statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one form
of identification (for example, a government-issued photo ID, driver's
license, or passport) and to state the purpose of their visit.
Information is also available on the Institute's/Center's home
page: https://acd.od.nih.gov, where an agenda and any additional
information for the meeting will be posted when available.
Dated: May 8, 2013.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-11352 Filed 5-13-13; 8:45 am]
BILLING CODE 4140-01-P